Umoja Biopharma, Inc. (Umoja), a transformative immunotherapy company creating off-the-shelf treatments that aim to extend the reach and effectiveness of CAR-T cell therapies in oncology and ...

Elicera Therapeutics describes how CAR T cells armed with neutrophil-activatingprotein can improve cancer therapy by inducing ...

Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, ...

Visos teisės saugomos. © 2024 UAB „Lrytas“. Kopijuoti, dauginti, platinti galima tik gavus raštišką UAB „Lrytas“ sutikimą.

Carmen Walker's sons, along with a surgeon who observed the procedure, say the blood loss that led to her death was ...

A new study published in Cell Reports Medicine reveals critical insights into the role of gamma-delta T cells across 33 ...

A new study reveals critical insights into the role of gamma-delta T cells across 33 cancer types, shedding light on their potential as clinical biomarkers and therapeutic targets in cancer treatment.

One woman and two men with severe autoimmune conditions have gone into remission after being treated with bioengineered and ...

BriaCell Therapeutics announced that its Bria-IMT cell therapy, plus an immune checkpoint inhibitor regimen, achieved ...

In the first study to report real-world outcomes from ciltacabtagene autoleucel (cilta-cel), a chimeric antigen receptor (CAR ...

Immunotherapy biologics represent a transformative approach in treating cancer and infections by using biological molecules to strengthen the immune system’s response. Biologics such as monoclonal ...